ANIK  valuation analysis

Basics
Name: Anika Therapeutics, Inc
Description: Anika Therapeutics, Inc., together with its subsidiaries, operates as an integrated joint preservation, restoration, and regenerative solutions company in the United States, Europe, and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Mar 04, 2021
Market cap: $586.92M (1350th)
Sales(TTM): $130.46M (1377th)
Earnings(TTM): -$23.98M (1102nd)

Value
FFER: 0.56 (why)
Actual price: $40.96
FFEThis is Anika Therapeutics, Inc's the estimated price. FFEs are the denominator of the FFER ratio.: $64.57
Quantile: ANIK is very cheap given its fundamentals.
Prices as of EOD 2021-04-14
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Anika Therapeutics, Inc's earnings decreased from $27.19M to -$23.98M in the last year.
  • Anika Therapeutics, Inc's operating income decreased from $34.25M to -$28.32M in the last year.
Earnings / MarketCap
Anika Therapeutics, Inc
"Biotechnology" industry
Sales / MarketCap
Anika Therapeutics, Inc
"Biotechnology" industry
Book / MarketCap
Anika Therapeutics, Inc
"Biotechnology" industry
Equity / Assets
Anika Therapeutics, Inc
"Biotechnology" industry